Jump to content

Picilorex

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Boghog (talk | contribs) at 21:48, 28 November 2020 (consistent citation formatting). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Picilorex
Clinical data
Other namesUP 507-04
ATC code
  • None
Identifiers
  • 3-(4-Chlorophenyl)-5-cyclopropyl-2-methylpyrrolidine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H18ClN
Molar mass235.76 g·mol−1
3D model (JSmol)
  • CC1C(CC(N1)C2CC2)c3ccc(cc3)Cl
  • InChI=1S/C14H18ClN/c1-9-13(8-14(16-9)11-2-3-11)10-4-6-12(15)7-5-10/h4-7,9,11,13-14,16H,2-3,8H2,1H3
  • Key:PZJBWSQQDMRZHY-UHFFFAOYSA-N

Picilorex (INN; brand name Roxenan) is an anorectic which is no longer marketed.[1][2][3] It is a monoamine reuptake inhibitor.[2]

References

  1. ^ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 1599–. ISBN 978-0-412-46630-4.
  2. ^ a b Milne GW (1 January 2001). Ashgate Handbook of Autonomic Nervous System Agents. Wiley. ISBN 978-0-566-08384-6.
  3. ^ World Health Organization (2000). International Nonproprietary Names (INN) for Pharmaceutical Substances. World Health Organization. ISBN 978-0-11-986227-0.



Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Picilorex&oldid=991210413"